Literature DB >> 3985490

Early thoracotomy and decortication for nontuberculous empyema in adults with and without underlying disease. A twenty-five year review.

P Mayo.   

Abstract

The present review deals with 63 adult patients having acute nontuberculous empyema treated by early thoracotomy and decortication, during the period from 1955 through 1979. Group I (38 patients) had postpneumonic empyema, but no underlying disease. Group II (25 patients) had acute empyema and one or more serious associated diseases. Positive cultures were present in 45 of 63 patients (71.4%). Most surgeons have customarily recommended conservative management, especially for patients in Group II, because of the supposedly "high risk" involved in decortication. Consequently, the mortality is extremely high. The empyema must be cured; a "well drained" or "controlled" empyema will not suffice. The severely ill patient can better withstand the ordeal of a major operation than the deleterious effects of a lingering empyema. The critically ill patient is best managed by the primary procedure of open thoracotomy and decortication. The author's experience confirms that such patients can expect an outlook (8% mortality) approaching the zero mortality of Group I patients.

Entities:  

Mesh:

Year:  1985        PMID: 3985490

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  Decortication for chronic parapneumonic empyema: results of a prospective study.

Authors:  Giulio Melloni; Angelo Carretta; Paola Ciriaco; Giampiero Negri; Carlopietro Voci; Giuseppe Augello; Piero Zannini
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

2.  Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage.

Authors:  H K Storm; M Krasnik; K Bang; N Frimodt-Møller
Journal:  Thorax       Date:  1992-10       Impact factor: 9.139

3.  Risk of empyema in patients with COPD.

Authors:  Hsueh-Yi Lu; Kuang-Ming Liao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.